Annie S. Chow
Adelaide, SA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.
Journal: British journal of haematology
Published: March 20, 2015
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
Journal: Epigenetics
Published: December 09, 2014
Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo.
Journal: Experimental cell research
Published: July 25, 2014
Alpha thalassaemia due to non-deletional mutations on the -3.7 alpha globin fusion gene: laboratory diagnosis and clinical importance.
Journal: Pathology
Published: September 11, 2013
Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma.
Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma.
Journal: British journal of haematology
Published: November 19, 2012
Prognostic nomogram for diffuse large B-cell lymphoma incorporating the International Prognostic Index with interim-positron emission tomography findings.
Journal: Internal medicine journal
Published: November 08, 2012
Relapsed multiple myeloma: who benefits from salvage autografts?
Journal: Internal medicine journal
Published: May 03, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026